East Asia Pharmaceutical Co., Ltd. (605177.SH): Quetiapine raw material medicine obtained a South Korean raw material medicine registration certificate.

Wisdom Financial News APP news, Dongya Pharmaceuticals (605177.SH) announced that the company recently received a raw material drug registration certificate from the Korean Food and Drug Administration (Korean MFDS). Domperidone has a dual regulatory effect that promotes gastric motility insufficiency or inhibits gastric motility excess, and can be used to treat symptoms such as loss of appetite, nausea, vomiting, belching, bloating, bowel sounds, abdominal pain, and diarrhea or constipation caused by gastrointestinal motility disorders. According to relevant data, the national sales of domperidone maleate preparations in 2024 are estimated to be about 372 million yuan.